DPYSL2 and ischemic stroke: Another study examining the role of 30 days TTST gavage in the chronic phase of the ischemic stroke demonstrated that TTST improved gait impairment in MCAO rats by activating axonal remodeling and the PI3K/AKT/GSK-3/CRMP-2 pathway (Yang et al., 2021b).